Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C101893
http://purl.obolibrary.org/obo/NCIT_C101893
|
|---|---|
| Preferred Name | HLA-A*2402-Restricted Multipeptide Vaccine S-488410 |
| Definitions |
A cancer vaccine composed of HLA-*2402-restricted epitopic peptides derived from three cancer/testis (CT) antigens, with potential antineoplastic activity. Upon subcutaneous administration, HLA-A*2402-restricted multipeptide vaccine S-488410 may elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing these CT antigens. CT antigens, normally expressed only in germ cells of the testis, are overexpressed in a wide variety of human cancers.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A cancer vaccine composed of HLA-*2402-restricted epitopic peptides derived from three cancer/testis (CT) antigens, with potential antineoplastic activity. Upon subcutaneous administration, HLA-A*2402-restricted multipeptide vaccine S-488410 may elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing these CT antigens. CT antigens, normally expressed only in germ cells of the testis, are overexpressed in a wide variety of human cancers. |
|---|---|
| prefLabel | HLA-A*2402-Restricted Multipeptide Vaccine S-488410
|
| label | HLA-A*2402-Restricted Multipeptide Vaccine S-488410
|
| NCI_META_CUI | CL436276
|
| PDQ_Closed_Trial_Search_ID | 733798
|
| code | C101893
|
| prefixIRI | NCIT:C101893
|
| in_subset | |
| Preferred_Name | HLA-A*2402-Restricted Multipeptide Vaccine S-488410
|
| Maps_To | HLA-A*2402-Restricted Multipeptide Vaccine S-488410
|
| NCI_Drug_Dictionary_ID | 733798
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 733798
|
| Semantic_Type |
Pharmacologic Substance
Immunologic Factor
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |